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Introduction
Cerebral Palsy (CP) refers to a range of conditions 
characterised by impairments in the child’s ability to 
move or control their movement; these impairments are 
caused by damage or lesions to the brain that usually 
occur before, during, or shortly after birth. 
Across Europe, approximately 2 in every 1,000 live births 
are affected by CP, and CP is the most common cause of 
physical disability in children. Clinicians have typically 
focused on recognising and treating the motor problems 
that characterise this condition. 
However, recent studies have highlighted that pain 
is a key factor that limits these children’s ability to 
participate in everyday activities and optimise their 
quality of life.  
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The prevalence and role of pain
Children with CP may experience increased tone or 
stiffness in the muscles, which can cause pain. Indeed, 
estimates from representative samples of children and 
young people with CP suggest that approximately 70% 
of the population had experienced pain in the previous 
week.
In a study where we linked administrative data with 
the Northern Ireland Cerebral Palsy Register, 61% of 
persons with CP aged between 4 and 31 had received 
pain medication between 2010 and 2014: This was 
significantly higher compared to the 51% of the 
general Northern Ireland population that received pain 
medication in the same period. These findings provide 
convergent evidence that pain-related issues are more 
prevalent and significant among people with CP. 
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Experiencing pain is not solely a distressing experience, 
but evidence also shows that it represents a significant 
obstacle for the developmental opportunities of children 
and young people with CP. 
In particular, pain experienced during childhood may limit 
opportunities to take part in a range of key activities, such 
as school activities (e.g. taking part in lessons, or after-
school clubs), or recreational activities (e.g. sports, arts 
and crafts, cultural events). Reduced participation in age-
appropriate activities can in turn curtail developmental 
opportunities. Furthermore, pain is significantly linked with 
poorer quality of life in childhood and adolescence.
When and how to assess pain 
In recognition of the prevalence and role of pain among 
children and young people with CP, NICE guidelines 
recommend that pain and distress should be discussed 
at every clinical contact. Despite this, evidence shows 
that only over a third (36%) of paediatric outpatient 
organisations in the UK follow these recommendations and 
ask regularly about the presence of pain. 
In community and disability paediatric organisations, this 
figure is marginally higher, with 41% of these organisations 
across the UK asking regularly about pain during 
consultations. 
One of the obstacles in assessing pain among children and 
young people with CP lies in the fact that communication 
difficulties and cognitive problems may be present in this 
population. In particular, those with more severe forms 
of CP may be the most affected by pain, but are also 
those more likely to display significant communication 
and cognitive difficulties. Assessing pain in these children 
may be particularly challenging: pain may thus remain 
undetected and not treated among those that may be 
more severely affected by it.
  These results highlight that, 
unless addressed, problems and 
issues related to pain during key 
stages of development can hamper 
the wellbeing, development, and 
attainment of the children affected.
Title: Dispensation of pain medication by severity of cerebral 
palsy 
Legend: Adjusted OR (and 95% CI) of pain-specific medication 
(NSAIDs, opioid & non-opioid analgesics) for different levels of 
severity of cerebral palsy severity classified using the Gross Motor 
Function Classification System
Intervention
Once problems related with pain and discomfort are 
assessed, NICE guidelines recommend treating reversible 
causes of pain using specific and targeted intervention for the 
root problem. 
However, in persons with CP the causes of pain may be 
complex and multifaceted, involving motor and muscle 
problems, other problems associated with the condition  
(e.g. gastro-intestinal problems), and psychological problems 
(e.g. anxiety and depression).  
When pain and discomfort are linked to spasticity, NICE 
guidelines suggest the use of physical therapies to prevent 
pain. Oral drugs such as diazepam and oral bacoflen are 
also recommended to manage pain. The use of pump-
administered intrathecal bacoflen is suggested whenever 
pain persists in spite of non-invasive treatments. 
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In our data-linkage study that looked at dispensed drugs 
between 2010 and 2014, people with CP were more 
likely to be in receipt of non-opiods, muscle relaxants, 
and axiolitics when they displayed more severe motor 
impairments. This evidences the complex needs of this 
population, and the variety of management options 
employed to treat pain and discomfort. 
Recommendations and Conclusion
The need to regularly assess pain and discomfort is 
paramount. To this end, the use of standardised tools to 
identify pain and assess its severity is crucial. 
The choice of tools should be guided by the profile of 
communication and cognitive difficulties of the child. 
Different tools (e.g. the Paediatric Pain Profile, the 
Numeric Pain Rating Scale) have been developed and 
clinically validated among children with and without 
significant communication problems respectively. 
The treatment of pain and discomfort also requires some 
understanding of the causes of pain: these can 
be multi-faceted, and often are not just the result of 
spasticity and muscle tone problems. Multidisciplinary 
teams are therefore crucial in investigating these 
causes and in the subsequent management of pain. For 
example, NICE guidelines recommend monitoring the 
impact that psychological problems such as anxiety and 
depression have in moderating pain: these can be better 
assessed and tackled by psychology and mental health 
professionals. 
In conclusion, pain experienced by children and 
young people with CP may limit their opportunities of 
developing and realising their potential: recognising 
and addressing pain early is critical to avoid long-term 
effects that can ultimately lead to failure to attain key 
skills, and impact on quality of life. Recognising and 
assessing pain in this population is a first necessary step, 
and professionals should strive to routinely implement 
the use of standardised and reliable measurement tools. 
Understanding the causes of pain and intervening on 
them requires concerted efforts by different professional 
figures liaising in multidisciplinary teams.
Title: Dispensation of pain medications in people with cerebral palsy by deprivation quintile of residence
Legend: Adjusted OR (and 95% CI) of pain-specific medication (NSAIDs, opioid and non-opioid analgesics) by deprivation 
quintile (Northern Ireland Multiple Deprivation Measure 2010)
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